Z-2452-2021Class II
Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
Cellex / initiated 2021-03-01 / Open, Classified
Cellex began a recall of Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue" on . FDA classified it as Class II and gives the reason as "The kit does not have an emergency use authorization (EUA)". As of , the recall status on record is Open, Classified.
Recall record
- Recall number
- Z-2452-2021
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- Cellex
- Product
- Cellex qSARS-Cov-2 Antigen Rapid Test, 25 tests/box, submitted as EUA202955 "declined to issue"
- Product code
- QKP Coronavirus Antigen Detection Test System.
- Reason for recall
- The kit does not have an emergency use authorization (EUA).
- FDA root cause
- Under Investigation by firm
- Action
- The recall was initiated via phone. The date the telephone calls were made is unknown but may have occurred late February, early March, 2021, based on the date returns started being made to the recalling firm. The firm issued their initial letters dated 6/15/2021 via email as a result of not having documentation of the phone calls. Later notifications were also issued or verbally discussed, with the latest notification occurring 8/20/2021.
- Quantity in commerce
- Approximately 44,821 kits
- Distribution
- US Nationwide distribution in the states of CA, FL, TX, and WI.
- Product codes and lots
- All lot numbers
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2452-2021 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
